182 related articles for article (PubMed ID: 20455647)
1. Conference scene: Challenges to commercialization.
Ilic D; Gentleman E
Regen Med; 2010 May; 5(3):341-3. PubMed ID: 20455647
[No Abstract] [Full Text] [Related]
2. How do we assess regenerative success after stem cell implantation? An experimental approach.
Hoehn M
Regen Med; 2011 Jul; 6(4):417-9. PubMed ID: 21749198
[No Abstract] [Full Text] [Related]
3. Allogeneic and autologous mode of stem cell transplantation in regenerative medicine: which way to go?
Mamidi MK; Dutta S; Bhonde R; Das AK; Pal R
Med Hypotheses; 2014 Dec; 83(6):787-91. PubMed ID: 25456787
[TBL] [Abstract][Full Text] [Related]
4. A chemical approach to stem-cell biology and regenerative medicine.
Xu Y; Shi Y; Ding S
Nature; 2008 May; 453(7193):338-44. PubMed ID: 18480815
[TBL] [Abstract][Full Text] [Related]
5. Industry highlights: Stem cell and regenerative medicine.
Ilic D
Regen Med; 2011 Nov; 6(6 Suppl):55-60. PubMed ID: 21999262
[No Abstract] [Full Text] [Related]
6. Current status of stem cells and regenerative medicine research in Argentina.
Pitossi FJ; Podhajcer OL
Stem Cells Dev; 2014 Dec; 23 Suppl 1():17-9. PubMed ID: 25457955
[TBL] [Abstract][Full Text] [Related]
7. Trachea transplants test the limits.
Vogel G
Science; 2013 Apr; 340(6130):266-8. PubMed ID: 23599456
[No Abstract] [Full Text] [Related]
8. Fifth Annual Stem Cell Summit.
Knowlton D
IDrugs; 2010 Apr; 13(4):235-8. PubMed ID: 20373251
[TBL] [Abstract][Full Text] [Related]
9. Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials.
Mizuno H
Curr Opin Mol Ther; 2010 Aug; 12(4):442-9. PubMed ID: 20677095
[TBL] [Abstract][Full Text] [Related]
10. ISSCR 2009 Industry Panel Session: promoting translation and commercialization.
Mason C
Cell Stem Cell; 2009 Oct; 5(4):379-84. PubMed ID: 19796618
[TBL] [Abstract][Full Text] [Related]
11. Introduction to stem cells and regenerative medicine.
Kolios G; Moodley Y
Respiration; 2013; 85(1):3-10. PubMed ID: 23257690
[TBL] [Abstract][Full Text] [Related]
12. Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine.
Mizuno H; Tobita M; Uysal AC
Stem Cells; 2012 May; 30(5):804-10. PubMed ID: 22415904
[TBL] [Abstract][Full Text] [Related]
13. The commercialization of regenerative medicine into a routine healthcare offering. Interview by Emily Culme-Seymour.
Deans R
Regen Med; 2013 May; 8(3):251-6. PubMed ID: 23634984
[No Abstract] [Full Text] [Related]
14. Interview. From canaries to the clinic.
Goldman SA
Regen Med; 2008 Sep; 3(5):655-9. PubMed ID: 18729789
[No Abstract] [Full Text] [Related]
15. Adipose-derived mesenchymal stem cells and regenerative medicine.
Konno M; Hamabe A; Hasegawa S; Ogawa H; Fukusumi T; Nishikawa S; Ohta K; Kano Y; Ozaki M; Noguchi Y; Sakai D; Kudoh T; Kawamoto K; Eguchi H; Satoh T; Tanemura M; Nagano H; Doki Y; Mori M; Ishii H
Dev Growth Differ; 2013 Apr; 55(3):309-18. PubMed ID: 23452121
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cell technology for the study of human disease.
Lee G; Studer L
Nat Methods; 2010 Jan; 7(1):25-7. PubMed ID: 20038952
[No Abstract] [Full Text] [Related]
17. Migratory properties of mesenchymal stem cells.
Dittmar T; Entschladen F
Adv Biochem Eng Biotechnol; 2013; 129():117-36. PubMed ID: 22899378
[TBL] [Abstract][Full Text] [Related]
18. Enhancing stem cell survival in vivo for tissue repair.
Hyun JS; Tran MC; Wong VW; Chung MT; Lo DD; Montoro DT; Wan DC; Longaker MT
Biotechnol Adv; 2013; 31(5):736-43. PubMed ID: 23153460
[TBL] [Abstract][Full Text] [Related]
19. Stem cell applications in regenerative medicine for neurological disorders.
Liu SP; Fu RH; Huang SJ; Huang YC; Chen SY; Chang CH; Liu CH; Tsai CH; Shyu WC; Lin SZ
Cell Transplant; 2013; 22(4):631-7. PubMed ID: 23127757
[TBL] [Abstract][Full Text] [Related]
20. The need for a regen industry voice.
Mason C; Dunnill P
Regen Med; 2008 Sep; 3(5):621-31. PubMed ID: 18729785
[No Abstract] [Full Text] [Related]
[Next] [New Search]
